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Even-skippedfamily of transcription factors that regulate many developmental processes in
vertebrates and invertebrates. In addition to their roles in regulating embryonic heart and epidermal
development in Drosophila, we provide evidence that the T-box transcription factors neuromancer1 (nmr1)
and neuromancer2 (nmr2) play key roles in embryonic CNS development. We verify that nmr1 and nmr2
function in a partially redundant manner to regulate neuronal cell fate by inhibiting even-skipped (eve)
expression in speciﬁc cells in the CNS. Consistent with their redundant function, nmr1 and nmr2 exhibit
overlapping yet distinct protein expression proﬁles within the CNS. Of note, nmr2 transcript and protein are
expressed in identical patterns of segment polarity stripes, deﬁned sets of neuroblasts, many ganglion
mother cells and discrete populations of neurons. However, while we observe nmr1 transcripts in segment
polarity stripes and speciﬁc neural precursors in early stages of CNS development, we ﬁrst detect Nmr1
protein in later stages of CNS development where it is restricted to discrete subsets of Nmr2-positive
neurons. Expression studies identify nearly all Nmr1/2 co-expressing neurons as interneurons, while a single
Eve-positive U/CQ motor neuron weakly co-expresses Nmr2. Lineage studies map a subset of Nmr1/2-
positive neurons to neuroblast lineages 2–2, 6–1, and 6–2 while genetic studies reveal that nmr2 collaborates
with nkx6 to regulate eve expression in the CNS. Thus, nmr1 and nmr2 appear to act together as members of
the combinatorial code of transcription factors that govern neuronal subtype identity in the CNS.
© 2008 Elsevier Inc. All rights reserved.IntroductionT-box transcription factors play general and conserved roles to
regulate the development of all metazoans. For example, T-box genes
are known to regulate mesoderm formation, morphogenetic move-
ments, cell adhesion, cell migration, tissue patterning, limb pattern-
ing, limb bud outgrowth, and organogenesis (King et al., 2006; Fong et
al., 2005; Naiche et al., 2005; Showell et al., 2004; Chapman and
Papaioannou, 1998; Papaioannou and Silver, 1998; Gibson-Brown et
al., 1998). Moreover, an evolutionary conserved role for T-box genes to
specify cell fates is supported by studies in simple organisms ranging
from sponges, which contain several T-box genes (Larroux et al., 2006;
Adell and Muller, 2005), to more complex invertebrate and vertebrate
organisms, which can contain up to 21 T-box genes (Naiche et al.,
2005; Woollard, 2005). In Drosophila melanogaster, eight T-box genes
from four subfamilies have been identiﬁed; these include Dorsocross-1
(Doc1), Doc2, Doc3, optomotor blind (omb), optomotor-blind-relatediences, University of Southern
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l rights reserved.(org-1), brachyenteron (Byn), neuromancer1 (nmr1/H15), and neuro-
mancer2 (nmr2/midline) (Reim and Frasch, 2005; Reim et al., 2005;
Buescher et al., 2004; Grifﬁn et al., 2000; Singer et al., 1996; Poeck et
al., 1993). nmr1 and nmr2 are members of the Tbx20 gene family and
regulate epidermal patterning as well as cardioblast speciﬁcation in
Drosophila (Buescher et al., 2006; Reim et al., 2005; Qian et al.,
2005, Miskolczi-McCallum et al., 2005; Buescher et al., 2004).
Since mutations in T-box genes are associated with human
congenital heart defects (Stennard and Harvey, 2005; Takeuchi et al.,
2005; Jerome and Papaioannou, 2001; Basson et al., 1999; Li et al.,
1997), a majority of studies have focused on the role of Tbx20 and
other T-box genes in regulating vertebrate embryonic heart develop-
ment. In chick, zebraﬁsh, and frog embryos, Tbx20 orthologues are
expressed in developing cardiovascular structures and regulate the
expression of Tbx5, a heart morphogenic gene important for the
development of the early heart tube as well as chamber formation
(Showell et al., 2006; Brown et al., 2005; Plageman and Yutzey, 2004;
Szeto et al., 2002; Ahn et al., 2000). Morpholino oligonucleotide
knockdown of zebraﬁsh Tbx20 (hrT) and frog Tbx20 results in small,
malformed hearts and a loss of blood circulation (Brown et al., 2005;
Szeto et al., 2002). Likewise, mouse Tbx20mutants exhibit hypoplastic
hearts with severe looping defects and abnormalities in cardiac
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Consistent with its fundamental role in cardiogenesis, mouse Tbx20
modulates the expression of Nkx2-5, Gata4 and Mef2c, members of
the core cardiac transcription factor network, in the developing heart
(Cai et al., 2005; Singh et al., 2005; Stennard et al., 2005; Takeuchi et
al., 2005; Stennard et al., 2003).
The Drosophila Tbx-20 homologues, nmr1 and nmr2, have been
shown to regulate two separable functions during cardiogenesis.
Initially, nmr1 and nmr2 cooperate with the NK-2 class homeodomain
transcription factor tinman and the GATA factor pannier to specify the
fates of cardiac progenitor cells (Reim et al., 2005; Qian et al., 2005;
Miskolczi-McCallum et al., 2005). In addition, nmr2 mutant embryos
exhibit increased numbers of even-skipped-expressing cardiac pro-
genitors at the expense of ladybird-expressing cardiac progenitors
(Qian et al., 2005). After specifying cardiac cell fates, nmr1 and nmr2
regulate the epithelial polarity of myocardial cells as repression of
nmr1 and nmr2 results in the mislocalization of the junctional
proteins Discs-large, Dystroglycan, and alpha-Spectrin (Qian et al.,
2005). Thesemolecular defects likely lead to the disorganization of the
heart tube and misalignment of heart cells consistent with defects in
cell adhesion (Fong et al., 2005).
Whilemuch research has focused on the function of Tbx20 genes in
heart development, a few studies have indicated a likely function for
this gene family during CNS development. For example, Tbx20 genes
are expressed in cranial motor neurons in zebraﬁsh, mice, and C.
intestinalis and in dorsal motor neurons in the chick spinal cord
(Nordstrom et al., 2006; Song et al., 2006; Dufour et al., 2006; Ahn et
al., 2000). Moreover, mab-9, the Caenorhabditis elegans Tbx20 family
member, is expressed in neurons located in speciﬁc regions of the
ventral nerve cord (Woollard and Hodgkin, 2000). Drosophila nmr1
and nmr2 transcripts are also detected in the mature embryonic CNS
(Qian et al., 2005) and loss of nmr1 and nmr2 results in an increase in
eve-expressing neurons (this study; Buescher et al., 2006).
In Drosophila nmr1 and nmr2 negatively regulate Wingless
signaling in the ventral epidermis to establish proper segmentation
(Buescher et al., 2004). In early stages of CNS development, nmr2
promotes the formation and speciﬁcation of several neuroblasts in the
CNS (Buescher et al., 2006). However, the roles of nmr1 and nmr2 in
regulating later steps of CNS development in Drosophila remain
largely unexplored. Through a forward genetic screen we identiﬁed
nmr1 and nmr2 as regulators of neuronal subtype identity in the
Drosophila CNS. nmr1 and nmr2 function in a partially redundant
manner to regulate neuronal speciﬁcation and in agreement with this,
are expressed in overlapping patterns of CNS neurons. Nmr1 and
Nmr2 expression appear predominantly conﬁned to interneurons, and
lineage tracing studies map subsets of Nmr1-positive neurons to three
speciﬁc neuroblast lineages. Taken together, these data suggest that
nmr1 and nmr2 are additional members of the transcriptional
regulatory network that speciﬁes neuronal fates in the Drosophila
embryonic CNS, and that elucidating their function will further our
understanding of the mechanisms guiding CNS development.
Materials and methods
Fly stocks
D. melanogaster strains were maintained at 25 °C on cornmeal–
yeast–agar media. white[1] ﬂies were used as wild-type. We used the
following lines in the study: Df(2L)sc19-4 (Bloomington Stock Center),
Df(2L)x528 (Buescher et al., 2004, 2006), nmr1210 (Qian et al., 2005),
midGA174 (Seeger et al., 1993), mid2 (Nusslein-Vohard et al., 1984),
eveID19 (Nusslein-Volhard et al., 1985), hb9kk30 (Broihier and Skeath,
2002), nkx6D25 (Broihier et al., 2004), and PZ[lac-Z;ry+]H15 ((H15-
lacZ); Brook and Cohen (1996)). We generated the double-mutant
lines nmr1210;hb9kk30, nmr1210;nkx6D25, midGA174;hb9kk30 (nmr2;hb9),
and midGA174;nkx6D25 (nmr2;nkx6). We used the Gal4/UAS system(Brand and Perrimon,1993) and Elav-Gal4 (Lin and Goodman,1994) to
misexpress the following transgenes in wild-type and speciﬁc mutant
backgrounds: UAS-nmr1, UAS-nmr2 (Qian et al., 2005) and UAS-eve
(Landgraf et al., 1999). Due to the observed post-transcriptional
regulation of nmr1 in embryos, we veriﬁed that ElavGAL4::UAS-nmr1
drove generalized Nmr1 protein expression in the CNS via standard
immunochemical methods. Embryos used for the lineage analyses
were of the following genotype: y w hsFlp/+; UAS-tau-myc-GFP/+;
ﬂpout-Gal4/+.
Antibody production, immunoﬂuorescent, and immunohistochemical
studies
Amino acids 1–287 of Nmr1 (N-terminal) and 322–557 of Nmr2 (C-
terminal) were cloned into pET (Novagen) for protein expression and
puriﬁcation. These protein fragments were used as immunogens to
generate antibody responses speciﬁc to Nmr1 in rabbits and guinea
pigs and to Nmr2 in rabbits at Pocono Rabbit Farm and Laboratory.
Both Nmr1 and Nmr2 antibodies are speciﬁc as demonstrated by their
inability to detect the expression of any other proteins in Drosophila
homozygous mutant for null alleles of nmr1 and nmr2, respectively.
We used the Vector ABC kit for immunocytochemical staining and
Alexa 488, Alexa 594, and Alexa 633 with appropriate species
speciﬁcity for immunoﬂuorescence studies (Molecular Probes). We
followed standard protocols published by N.H. Patel (1994) for both
immunocytochemical and immunoﬂuorescent staining.
We used the following primary antibodies at the indicated
dilutions for this study: rabbit anti-Eve (1:3000; Frasch et al., 1987),
mouse anti-Repo (1:100; Halter et al., 1995), rat anti-Nkx6 (1:1000;
Broihier et al., 2004), guinea pig anti-Hb9 (1:1000; Broihier and
Skeath, 2002), mouse anti-Zfh-1 (1:1000; Lai et al., 1993), rabbit anti-
Mef2 (1:3000; Lilly et al., 1995), rabbit anti-Gad (1:1000; a gift of F.R.
Jackson; Kulkarni et al., 1994), rabbit anti-Serotonin (1:300; a gift of P.
Taghert; Taghert and Goodman, 1984), rabbit anti-DVGLUT (1:10,000;
a gift of A. DiAntonio; Daniels et al., 2004), rabbit anti-Dbx (1:1000; J.
Skeath), guinea pig or rabbit anti-Nmr1 (1:3000; this work), and
rabbit anti-Nmr2 (1:1000; this work). The following primary
antibodies were obtained from the Developmental Studies Hybridoma
Bank at The University of Iowa: anti-Dac2-3 (1:10, Mardon et al.,
1994), anti-Fasciclin II (1D4, 1:5; Grenningloh et al., 1991), anti-
Engrailed/Invected (4D9, 1:10; Patel et al., 1989), and BP-102 anti-
Neurotactin (1:20; Hortsch et al., 1990). Rabbit (Jackson Laboratories)
and mouse (Promega) β-Galactosidase antibodies were used at a
dilution of 1:2000. Rabbit GFP antibody (Torey Pines) was used at a
1:3000 dilution. All secondary antibodies for immunocytochemical
staining were diluted at 1:300 (Vector Laboratories).
RNA in situ hybridization
In situ hybridization of Drosophila embryos was performed
essentially as described in Tautz and Pfeifﬂe (1989). To detect nmr1
RNA expressionwe generated two anti-sense digoxygenin RNA probes
speciﬁc for nmr1 using the T7 Megascript transcription kit (Ambion).
One region corresponded to exons 1 and 2 of nmr1 (798 bases). This
region almost completely overlaps with the fragment of nmr1 used to
generate recombinant Nmr1 protein for antibody generation, which
includes exons 1 and 2 and the ﬁrst 63 bases of exon 3. The other RNA
probe was generated from the full-length nmr1 cDNA (Qian et al.,
2005). Both probes detect identical nmr1 RNA expression patterns
in embryos.
Deﬁciency screening and deﬁciency mapping
We screened 200 deﬁciency lines contained within the second and
third chromosomal deﬁciency kits available from the Bloomington
Stock Center (IN) for alterations in the CNS expression pattern of Eve.
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Eve-positive neurons. We then used the following deﬁciencies to map
this Eve CNS phenotype to a smaller genomic interval: Df(2L)tkv2
(25D2;25E1), Df(2L)Exel6012 (25D5;25E6), Df(2L)cl2 (25D2;25F2), Df
(2L)cl-h2 (25D6;25F5), and Df(2L)cl-h4 (25E1;25E5). The latter
deﬁciency was the most useful for narrowing the genomic interval
of interest to 25E1;25E5 within which 16 predicted or known genes
reside. We obtained mutant alleles available for 6 of these genes and
screened embryos homozygous for each of these mutations for
alterations in the Eve CNS expression. Only the neuromancer2
(midline) mutant alleles, midGA174 and mid2, recapitulated the Df(2L)
sc19-4 eve mutant phenotype.
Lineage tracing analyses
We used a modiﬁed Flp/FRT (Flipase/Flp Recognition Target)
system developed by Harrison and Perrimon (1993) to map the
neuroblast lineage and trace axon projection patterns of neurons that
express Nmr1. We collected 0–2 h old embryos and aged them for 2, 4,
and 6 h at 25 °C. Each group of developmentally staged embryos was
collected and heat-shocked for seven minutes at 33 °C to induce ﬂp
recombinase, placed at 18 °C, and aged until stage 15–17. Embryos
were then collected, ﬁxed, and triple-stained with anti-Nmr1, anti-
GFP, and anti-Fas II. By varying the time of the Flp expression, we GFP-
labeled the whole neuroblast lineage or individual Nmr1-positive
neurons. Anti-Fas II labeled the axon connectives. Using confocal
microscopy, we obtained approximately 50–60 0.1 µm thick Z-series
of each nerve cord containing positive clones and compressed those
images into two dimensions using Leica software.
Software programs
The ﬁnal confocal images were assembled using Adobe Photoshop
software. Statistical analyses were performed using Microsoft Excel
and the data were presented graphically using Origin software
(Microcal Software, Inc.).Fig. 1. nmr2 represses eve expression in the Drosophila nerve cord. Stage 15 wild-type (A,B), D
type nerve cords eve labels 5–6 U/CQ, 10 EL, RP2, and aCC/pCC neurons as indicated. (C) In D
(D) there is a decrease in the presence of Eve-positive aCC/pCC neurons (brackets). (E,F) nm
sc19-4−/− embryos. Panels A, C, E — ventral views and panels B, D, F — dorsal views of the DResults
nmr2 and nmr1 are neuronal fate determinants
To identify genes that regulate neuronal cell fate in the Drosophila
embryonic CNS, we screened a collection of approximately 200 second
and third chromosomal deﬁciency lines for changes in the CNS
expression pattern of even-skipped (eve). We chose eve as a molecular
marker because eve regulates neuronal cell fates (Doe et al., 1988) and
is expressed in a stereotyped pattern of neurons in the CNS (Figs. 1A,
B). We focused our attention on Df(2L)sc19-4 (25D7;26A9) because
embryos homozygous for this deﬁciency exhibit ectopic Eve-positive
neurons in the lateral region of the CNS (Fig.1C) as well as a partial loss
of medial Eve-positive aCC/pCC neurons (Fig. 1D).
We used deﬁciency mapping to localize this genetic function to a
smaller interval and identiﬁed the T-box genes neuromancer1
(nmr1) and neuromancer2 (nmr2) as likely candidates to regulate
eve expression in the CNS (see Methods). Since nmr1 and nmr2
are known to regulate heart and epidermal development in the
Drosophila embryo and both are expressed in the CNS (Qian et al.,
2005; Buescher et al., 2004), we asked whether loss of function in
nmr1 and/or nmr2 yielded a phenotype similar to that observed
for Df(2L)sc19-4. Embryos homozygous for a null allele of nmr2
(midGA174) display an Eve CNS phenotype similar to but weaker than
that observed for embryos homozygous for Df(2L)sc19-4 (Fig. 1),
whereas embryos homozygous for a null allele of nmr1 (nmr1210)
exhibit a wild-type eve expression pattern (data not shown).
Thus, nmr2, but not nmr1, is necessary to regulate eve expression
in the CNS.
Prior work has shown that nmr1 and nmr2 function in a partially
redundant manner to control epidermal development in the Droso-
phila embryo with nmr2 playing a primary role in this process
(Buescher et al., 2004). To test whether nmr1 collaborates with nmr2
to regulate eve expression and to rule out the possibility that otherf(2L)sc19-4−/− (C,D), and nmr2−/− (E,F) mutant nerve cords stained for Eve. (A,B) In wild-
f(2L)sc19-4−/− mutant embryos, ectopic Eve-positive neurons arise laterally (arrows) and
r2−/− mutant embryos (midGA174) exhibit the same phenotype as that observed in Df(2L)
rosophila nerve cord; the vertical line marks the midline.
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phenotype, we removed both copies of nmr1 and nmr2 by generating
embryos trans-heterozygous for the original deﬁciency, Df(2L)sc19-4,
and a different deﬁciency, Df(2L)x528. The region of overlap between
these deﬁciencies speciﬁcally removes nmr1, nmr2, and an annotated
gene, CG31647, with unknown function (Buescher et al., 2004).
Embryos trans-heterozygous for these two deﬁciencies yielded a
phenotype identical to that observed for embryos homozygous for Df
(2L)sc19-4 (Buescher et al., 2004; data not shown). Thus, we conclude
that nmr1 and nmr2 function in a partially redundant manner to
control eve expression within the CNS.
Nmr2 and Nmr1 protein expression during embryogenesis
In order to identify the individual cells that express nmr1 and/or
nmr2, and to follow the expression dynamics of these two factors
during embryogenesis and neurogenesis we generated Nmr1 and
Nmr2 speciﬁc antibodies (see Methods). In general, we ﬁnd that Nmr2Fig. 2. Nmr1 and Nmr2 protein expression during embryogenesis. Nmr2 (A–D,L), Nmr1 (E–H
later stages of development (A) Stage 9 embryos express Nmr2 in segment polarity stripes. (B
the CNS (arrows) as well as in heart precursor cells in the dorsal mesoderm (arrowheads). (C)
each segment (arrows) and is also expressed in heart precursor cells (arrowheads). (D) By s
stripes of ectodermal cells (white arrows), and clusters of ectodermal cells (white arrowhea
nmr1 transcripts are clearly detected in segment polarity stripes. (F) Nmr1 protein is ﬁrst
similarly staged embryos express nmr1 transcripts in segment polarity stripes, neuronal prec
patterns of CNS neurons (arrows) and heart precursors in the mesoderm (arrowheads). (H, H
brackets), all cardioblasts as well as in narrow stripes of ectodermal cells (H, white arrows)
green; M, red) and Nmr2 (L, green) are co-expressed with Mef-2 (J, red) in all cardioblasts (K
Ventral, down.is expressed earlier and more broadly than Nmr1, with Nmr1
expression being restricted to subsets of Nmr2-expressing cells. We
also ﬁnd evidence for temporal regulation of Nmr1 protein translation
as we observe nmr1 transcripts in segment polarity stripes during
gastrulation (Buescher et al., 2006; Fig. 2), many hours before Nmr1
protein becomes detectable in a few cells in the CNS (Fig. 2). In
contrast, the RNA and protein expression proﬁles of Nmr2 appear
essentially identical (Buescher et al., 2006).
We ﬁrst detect Nmr2 expression during gastrulation (stage 6/7). At
this time and through stage 10 Nmr2 is expressed in segment polarity
stripes consistent with its known role in repressing wingless
expression during segmentation (Fig. 2A) (Buescher et al., 2004,
2006). During the remainder of embryogenesis Nmr2 is expressed in a
dynamic pattern in many tissues (Figs. 2B–D). In the CNS, Nmr2 is
expressed in subsets of neuroblasts, ganglion mother cells, and
neurons and by the end of embryogenesis marks about twenty
neurons per hemisegment. In the ectoderm, Nmr2 expression remains
in the ventral region of the embryo and is lost most dorsally. By the,I) and nmr1mRNA transcript (E′–H′) expression in wild-type embryos at progressively
) During early stage 12, Nmr2 is expressed in subsets of neuroblasts and their progeny in
During late stage 12, Nmr2 is expressed prominently in a medial pair of CNS neurons in
tage 16 Nmr2 is expressed in many neurons in the CNS (brackets), narrower transverse
ds) between these stripes. (E) Stage 9 embryos do not express Nmr1 protein while (E′)
detected during early stage 12 in a few cells in the cephalic region (arrow), (F′) while
ursors and neurons. (G, G′) By stage 13, Nmr1 protein and RNA are expressed in identical
′) By stage 16, Nmr1 protein and RNA are co-expressed in many neurons in the CNS (H,
. (I–N) High magniﬁcation views of the Drosophila heart at stage 16 show that Nmr1 (I,
,N). Whole mounts in the lateral orientation; Anterior, left; Posterior, right; Dorsal, up;
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ectodermal cells (white arrows, Fig. 2D) and small clusters of
ectodermal cells between these stripes (white arrowheads, Fig. 2D).
In the mesoderm, Nmr2 expression is restricted to the heart where
Nmr2 is expressed in all cardioblasts as well as their precursors (Figs.
2B,C,H–M).
In contrast to Nmr2, we ﬁrst detect Nmr1 protein during stage 12
in a few cells in the anterior portion of the CNS (Figs. 2F,G). From this
stage forward, the expression pattern of Nmr1 largely parallels that of
Nmr2 in the CNS, ectoderm and mesoderm; the only exception being
that only a subset of Nmr2-positive neuronal and ectodermal cells
express Nmr1 (Fig. 2G and Fig. 3I). The protein expression proﬁle of
Nmr1 is noteworthy for two reasons. One, comparisons of the Nmr1
protein and RNA expression patterns indicate that nmr1 transcript is
subject to post-transcriptional regulation during early but not late
embryogenesis. For example, while nmr1 RNA is expressed from stage
7 to stage 12 in a pattern very similar to that observed for nmr2
(Buescher et al., 2006; Figs. 2E′–H′), Nmr1 protein ﬁrst appears during
late stage 12 in a few cells in the CNS. From late stage 12 forward theFig. 3. Co-expression of Nmr2 and Nmr1 in the Drosophila CNS. Stage 13 (A,D,) stage 14 (B,E)
H, I) and co-labeled for Nmr1 and Nmr2 (I). (A) During stage 13 Nmr2 is expressed strongly
Nmr2 is expressed strongly in a cluster of approximately 10–15 cells per hemisegment wit
diminished expression laterally. (C) This pattern of expression is prominently deﬁned in stag
(box) and 8 lateral neurons (bracket). Nmr2 is also expressed weakly in about 5–6 neurons wi
number of medial neurons and expressedweakly in a few neurons in the intermediate region
observed in additional neurons in the intermediate regions of the CNS. (F) By stage 15,
approximately 3–5 neurons (box), a lateral cluster of 7–8 neurons (bracket), and a few dispe
stage 15 embryos indicates that a subset of Nmr2-positive neurons express Nmr1 (merge).Nmr1 protein and RNA patterns appear essentially identical (Figs. 2F–
G and F′–G′).
Two, we ﬁnd that the protein expression proﬁle of Nmr1 is not
identical to that driven by the H15-lacZ enhancer trap line, which is
inserted roughly 3 Kb upstream of nmr1, and has been used as a
surrogate for Nmr1 protein expression in embryos (Buescher et al.,
2006; Miskolczi-McCallum et al., 2005; Buescher et al., 2004). For
example, during late stages of CNSdevelopment (stages 13–16) double-
label studies indicate that while H15-lacZ labels all Nmr1-positive
neurons, many H15-lacZ-positive cells do not express Nmr1 protein
(Fig. S1). During earlier stages of development the two patterns do not
overlap as H15-lacZ drives expression in segment polarity stripes,
many NBs, and ganglion mothers cells, but as noted Nmr1 protein ﬁrst
becomes detectable during stage 12 in a few post-mitotic neurons. The
early pattern of H15-lacZ does appear essentially identical to the Nmr2
protein expression proﬁle. However, while more neurons co-express
H15-lacZ and Nmr2 than H15-lacZ and Nmr1 during late stages of CNS
development, many cells especially those near themidline still express
H15-lacZ but not Nmr2 (Fig. S1). Thus, theH15-lacZ expressionpattern,, and late stage 15 (C,F,G–I) wild-type embryos labeled for Nmr2 (A–C, G, I), Nmr1 (D–F,
in a cluster of medial neurons and weakly in a group of lateral neurons. (B) By stage 14,
h enhanced expression in the medial and intermediate regions of the nerve cord and
e 15 where Nmr2 is expressed strongly in a cluster of approximately 8 medial neurons
thin the lateral cluster (arrow). (D) During stage 13 Nmr1 is expressed strongly in a small
. (E) By stage 14, Nmr1 expression remains high inmedial neurons and expression is now
Nmr1 is expressed in many discrete sets of neurons in the CNS: a medial cluster of
rsed lateral neurons (arrow). (G–I) Double-labeling for Nmr2 (green) and Nmr1 (red) in
143S.M. Leal et al. / Developmental Biology 325 (2009) 138–150likely due to perdurance of β-galactosidase within neuroblasts and
neuroblast lineages that transiently express nmr1/2, appears to over-
estimate the protein expression proﬁles of Nmr1 and Nmr2 in the
mature embryonic CNS (see also below).
Nmr2 and Nmr1 expression in discrete neuronal populations of the CNS
We explored the CNS expression proﬁles of Nmr1 and Nmr2 in
greater detail to gain insight into their possible functions during CNS
development. The expression patterns of Nmr2 and Nmr1 are
dynamic and complex in the CNS with a number of distinguishing
features. Nmr2 and Nmr1 are expressed in several discrete clusters of
neurons in the CNS per hemisegment. A subset of cells within each
cluster of Nmr2-positive neurons expresses Nmr1, and the expression
of Nmr1 is delayed relative to that of Nmr2 in these cells. While
distinct clusters of neurons reproducibly express Nmr1/Nmr2 at
different levels, the relative expression levels of Nmr2 and Nmr1
within any one cluster are similar. The extensive co-expression of
Nmr1/2 in the CNS helps explain the partially redundant function of
these genes. Moreover, the temporal delay of nmr1 expression relative
to that of nmr2 in neurons together with the restriction of nmr1
expression to a subset of nmr2-positive neurons suggests the existence
of a positive regulatory relationship between nmr2 and nmr1.
To test for a regulatory relationship between nmr2 and nmr1 we
followedNmr1 protein expression in embryos that express Nmr2 in all
CNS neurons as well as in embryos that lack nmr2 function. First, we
used the Gal4/UAS system and the Elav-Gal4 driver line to express
nmr2 ectopically in all CNS neurons. This manipulation led to ectopic
nmr1 expression in most, if not all, cells in the CNS (Fig. 4) suggesting
that nmr2 can positively regulate nmr1 expression in many neurons.
However, the pattern and levels of nmr1 remain essentially normal in
embryos homozygous mutant for nmr2 (data not shown). The pattern
of nmr2 expression remains unchanged in embryos that lack nmr1
function as well as in those inwhich nmr1 is expressed throughout the
CNS using the Gal4/UAS system (Methods; data not shown). These
results underscore the complex regulatory relationship between nmr2
and nmr1 in the CNS as nmr2 appears sufﬁcient to activate nmr1 in
most neurons but is not necessary to promote nmr1 expression in any
neurons. Thus, other factors must act in parallel to nmr2 to activate or
to maintain nmr1 expression in neurons that co-express nmr1 and
nmr2, while distinct factors likely repress nmr1 in cells that only
express nmr2.
Nmr1 and Nmr2 mark a unique population of interneurons
Next, we sought to determine the speciﬁc subtype of cells that
express nmr1 and nmr2 in the CNS. We ﬁrst tested whether glia and/Fig. 4. Nmr2 enhances Nmr1 expression. Stage 15 embryonic nerve cords stained for
Nmr1. (A) Wild-type expression pattern of Nmr1 in the ventral nerve cord. (B)
Misexpression of Nmr2 in all post-mitotic neurons (ElavGAL4::UAS-nmr2) signiﬁcantly
enhances Nmr1 expression throughout the nerve cord.ormotor neurons express nmr1 and nmr2 by looking for co-expression
between Nmr1/Nmr2 and molecular markers of the glial (Repo) or
motor neuron fate (Eve, Hb9, Zfh-1) (Layden et al., 2006; Lundell et al.,
2003; Novotny et al., 2002; Isshiki et al., 2001; Skeath and Doe, 1998).
Repo and Nmr1/Nmr2 label largely complementary sets of cells in the
CNS with no co-expression observed between Repo and Nmr1 and
only one lateral glial cell expressing Nmr2 (Fig. S2). Similarly, Nmr1/
Nmr2 exhibit minimal co-expression with eve and Hb9 (Figs. 9H,I;
data not shown for Hb9), which together label most motor neurons
(Broihier and Skeath, 2002; Landgraf et al., 1997; Schmid et al., 1999;
Sink and Whitington, 1991). No Hb9-positive neurons express Nmr1
or Nmr2, while only one Eve-positive U/CQ neuron weakly expresses
Nmr2 (Fig. 9H). Zfh-1 is expressed in most motor neurons and some
interneurons in abdominal segments (Skeath and Doe, 1998; Layden
et al., 2006). Three Zfh-1 and Nmr2 co-expressing neurons are located
ventrally within each hemisegment (Figs. 5A–C) and one dorsal Zfh-1
neuron co-expresses Nmr2 and Nmr1within each hemisegment (Figs.
5D–F and Figs. 5J–L). Since the vast majority of Zfh-1-positive neurons
do not co-express Nmr2 or Nmr1, these analyses indicate that most
nmr1 and nmr2-expressing cells in the CNS are interneurons.
To determine if Nmr1/Nmr2-positive neurons identify any well-
characterized interneurons, we carried out additional double-labeling
studies and assayed for co-expression between Nmr1/Nmr2 and
Dachshund (Miguel-Aliaga et al., 2004), Engrailed (Bossing and Brand,
2006), or Apterous (Herzig et al., 2001; Lundgren et al., 1995), each of
which labels discrete sets of interneurons. We ﬁnd that Nmr1 and
Nmr2 are expressed inmutually exclusive sets of interneurons relative
to each of these markers. Thus, Nmr1 and Nmr2 identify subsets of
interneurons largely distinct from those that have previously been
characterized.
Our results contrast with prior work on Nmr1/Nmr2, which
indicated that these factors are expressed in the Engrailed-positive
ventral and dorsal channel glia as well as in the Engrailed-expressing
progeny of the midline neuroblast (Buescher et al., 2006). However,
we do not observe expression of Nmr1 or Nmr2 in any Engrailed
expressing neurons/glia in the CNS (Fig. S3). Thus, H15-lacZ expres-
sion in these cells likely arises due to earlier transient expression of
nmr1/nmr2 within neuroblast 7–4, the progenitor of the channel glia,
and the median neuroblast (Buescher et al. 2006). Consistent with
nmr2 acting during early steps of CNS development to regulate the
development and differentiation of cells in these two lineages, we
conﬁrmed that loss of nmr2 function leads to the disorganization and
occasional loss of the channel glia as well as the Engrailed-positive
progeny of the midline neuroblast, as observed previously by
Buescher et al. (2006).
Nmr1 and Nmr2 are expressed within interneurons derived from NB
lineages 2–2, 6–1, and 6–2
We used lineage tracing to begin to map the neuroblast lineages
that give rise to Nmr1-positive neurons. This technique also allowed
us to visualize the axon trajectories of Nmr1-positive neurons. Since
we demonstrate that Nmr2 labels all Nmr1-positive neurons (Fig.
3I), we are essentially mapping the neuroblast lineages giving rise to
subsets of Nmr1 and Nmr2 co-expressing neurons. Brieﬂy, we used
a modiﬁed version of the FLP/FRT lineage tracing system (Harrison
and Perrimon, 1993; see Methods) to create random clones of tau-
myc-GFP reporter gene expression. We screened lineage clones
within the embryonic CNS for those that contained at least one
Nmr1-positive neuron, and then identiﬁed the parental neuroblast
of Nmr1-positive neurons by comparing the location and morphol-
ogy of our lineage clones to the location and morphology of
identiﬁed neuroblast lineages as determined by DiL-labeling
(Schmid et al., 1997, 1999; Bossing et al., 1996). Through this
approach we identiﬁed the parental neuroblast lineage for three sets
of Nmr1-positive neurons (6 neurons) via the analysis of multiple
Fig. 5. Nmr1 and Nmr2 are detected in a few Zfh-1-expressing motor neurons. (A–L) Wild-type stage 15 embryos stained for Zfh-1 (red) and Nmr2 (green) or Nmr1 (green). (A–C) In
the ventral region of the CNS, Nmr2-positive and Zfh-1-positive neurons are co-expressed in approximately 2–3 neurons in the medial Nmr2-expressing cluster per hemisegment
(merge, arrows). (D–F) Dorsally in the CNS, a single lateral neuron co-expresses Nmr2 and Zfh-1 per hemisegment (merge, arrows). (G–I) In the ventral region of the CNS, no cells co-
express Nmr1 (green) and Zfh-1 (red). (J–L) In the dorsal region of the CNS, one lateral neuron weakly co-expresses Nmr1 and Zfh-1 per hemisegment (merge, arrows).
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For example, two clones in abdominal segments contained the same
medially-positioned Nmr1-positive neuron (Fig. 6C). This inter-
neuron resides within a large clone of approximately 12–15
interneurons and 1 motor neuron (Figs. 6A–D). The interneurons
project axons across the anterior commissure and then project
axons anteriorly and posteriorly along the medial and lateral Fas-II-
positive longitudinal fascicles (Fig. 6D). The motor neuron projects
its axon out the segmental nerve (Fig. 6D). The morphology of these
clones together with their relative location in a segment most
closely match those identiﬁed for NB 2–2 by DiL labeling studies
(Schmid et al., 1999). Thus, we place this medial Nmr1-positive
neuron within the 2–2 lineage (Fig. 7).
We used similar criteria to place two other sets of Nmr1-positive
neurons in deﬁned lineages. We identiﬁed two clones in abdominal
segments comprised of ~10 interneurons that contain both a medial
and intermediate positioned Nmr1-positive neuron (Figs. 6E,F). The
most striking feature of these clones is the cascade of ipsilateral axonbranches that extend posteriorly and span at least one segment (Figs.
6F,G). The ventral region of these clones contains two to three large
interneurons that project axons across the posterior commissure and
then turn anteriorly (Fig. 6G). These morphological features most
closely match those deﬁned by DiL labeling for the 6–1 lineage. Thus,
two speciﬁc Nmr1-positive neurons are derived from this lineage (Fig.
7) (Schmid et al., 1999; Bossing et al., 1996).
Finally we identiﬁed four clones each of which labeled the same
three Nmr1-positive neurons in abdominal segments. These neurons
are located in abdominal segments and their clones contain 12–18
interneurons (Figs. 6H–K) that extend two contralateral axon bundles
across the posterior commissure and a small ipsilateral axon branch.
In one clone the short ipsilateral axon branch formed a prominent
arch peaking towards the anterior end (Fig. 6K, inset). This arching
phenotype has been described as a distinguishing feature of a small
number of NB lineages including NB 6–2. Based on a close match
between themorphology and relative location of these clones to those
deﬁned for NB 6–2, we place these three Nmr1-positive neurons
Fig. 7. Expression pattern of Nmr1-positive neurons derived from NBs 2–2, 6–1 and and
6–2. The boxed sets of neurons highlight the Nmr1-positive neurons derived from NB
lineages 6–1 (left) and 6–2 (right). An open arrowhead points to the Nmr1-positive
neuron derived from the NB 2–2 lineage.
Fig. 6. A subset of Nmr1/2 expressing interneurons derived from neuroblast lineages 2–2, 6–1, and 6–2. Cartoons detail the positions and axon morphologies of Nmr1-positive
interneurons (red) within identiﬁed NB clones in the CNS of wild-type, stage 15–17 embryos. The most ventral neurons are shaded dark green. Neurons are drawn in relation to the
anterior and posterior commissures (AC/PC) and the longitudinal connectives (blue). From top (dorsal) to bottom (ventral) the compressed confocal images represent ~1 µM thick
sections of Nmr1-positive clones. The nerve cord is triple-labeled for Nmr1 (red), axons (green, anti-GFP), and longitudinal connectives (blue, anti-FasII). (A–D) A lineage clone that
contains one Nmr1-positive neuron (arrow) extends axons contralaterally (D, open arrowhead) and a motor neuron axon branch (D, closed arrowhead). (E–G) A lineage clone that
contains two Nmr1-positive interneurons (white arrows) extends a collateral axon branch (G, open arrowheads) and a cascade of ipsilateral axons (F,G, brackets). (H–K) A lineage
clone that contains three Nmr1-positive neurons (arrows) extends a small ipsilateral axon branch (J, open arrowhead) as well as anterior and posterior collateral axons. Occasionally,
NB 6–2 clones exhibit an ipsilateral axon branch with a prominent arch and this axonal phenotype was detected in a similar clone (K, inset).
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1996).
Medial Nmr1 and Nmr2 subsets of neurons are GABAergic
To gain insight into the potential function of Nmr1- and Nmr2-
positive neurons, we assayed whether Nmr1 and Nmr2 interneurons
express speciﬁc classes of neurotransmitters. While Nmr1 and Nmr2
neurons do not express serotonin (Taghert and Goodman,1984) or the
vesicular transporter for glutamate (DVGLUT) (Daniels et al., 2004)
(data not shown), a single medial Nmr1/Nmr2-positive neuron
strongly expresses vesicular glutamic acid decarboxylase (Gad) (Fig.
8). Gad is the biosynthetic enzyme for γ-aminobutyric acid (GABA)
(Jackson et al., 1990), an abundant inhibitory neurotransmitter
expressed throughout the embryonic CNS. Thus at least one medial
Nmr1/Nmr2-positive interneuron is competent to synthesize GABA
and to potentially modulate the activity of neural circuits.
nmr2 negatively regulates even-skipped expression
Our loss-of-function studies indicate that nmr1 and nmr2 are
necessary to repress eve expression in a few cells in the CNS (Fig. 1E),
thus we focused our attention on exploring the negative regulatory
relationship between nmr2 and eve. Speciﬁcally, we asked whether
nmr1 and nmr2 are sufﬁcient to repress eve expression. To do this
we used the Gal4/UAS system and Elav-Gal4 to drive nmr2 or nmr1
expression in all post-mitotic neurons of the CNS and assayed the
effect on eve expression (Fig. 9). Ubiquitous misexpression of nmr2
causes a signiﬁcant reduction of eve expression in all Eve-positive
neurons (Fig. 9B). In contrast, misexpression of nmr1 causes a very
mild reduction of eve expression in the CNS (Fig. 9C). Thus, nmr2 and
to a lesser extent nmr1 can inhibit eve expression in some, but not all,
CNS neurons. The mild phenotype observed upon generalized nmr1expression is not attributable to low level Nmr1 protein expression, as
ElavGAL4::UAS-nmr1 embryos display high levels of Nmr1 protein
throughout the CNS (data not shown).
In a reciprocal manner, we determined whether eve, a known
transcriptional repressor, can inhibit the expression of nmr1 and
nmr2. Wemisexpressed eve in all post-mitotic neurons using the Gal4/
UAS system and assayed the effect on Nmr1 or Nmr2 expression.
Ubiquitous eve expression in the CNS causes a dramatic reduction of
nmr2 and nmr1 expression in the CNS (Figs. 9D–G). However, eve
Fig. 8. A subset of medial Nmr2 and Nmr1 interneurons co-express glutamic acid decarboxylase. (A–C) Stage 15 nerve cords from the H15-LacZ reporter line, which labels all Nmr1-
positive and Nmr2-positive neurons. (A) Staining for glutamic acid decarboxylase (Gad) speciﬁcally identiﬁes GABAergic populations of interneurons (green). (B) Staining for β-
Galactosidase (B-Gal) marks all Nmr1 and Nmr2 positive neurons (red). (C) A prominent, medial pair of previously identiﬁed Nmr1 and Nmr2 co-expressing neurons detected within
each segment of the nerve cord accumulates a high level of vesicular Gad at the plasma membrane (arrows, merge).
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expression since eveID19, a temperature-sensitive allele of eve
(Nusslein-Volhard et al., 1985), exhibits normal numbers of Nmr1-
and Nmr2-positive neurons (data not shown). As noted, eve and nmr1/
nmr2 are expressed in mutually exclusive sets of neurons in the CNS
(Figs. 9H,I). Thus, the mutually cross-repressive actions of nmr2 and
eve likely help maintain their complementary expression patterns in
the CNS. In early embryonic CNS development, we also observed that
the loss of nmr2 resulted in the loss of eve expression in the aCC and
pCC neurons in predominantly odd-numbered segments (Fig. 1F).
Buescher et al. (2006) reported similar observations and attributed
this loss of Eve-positive aCC and pCC neurons to the failure of their
neuroblast precursor, NB 1–1, to form in odd-numbered segments
(Buescher et al., 2006).
nmr1 and nmr2 interact genetically with nkx6, a key regulator of eve
dhb9kk30 and nkx6D26 are two homeodomain transcription factors
known to inhibit eve expression in the CNS (Broihier et al., 2004;
Broihier and Skeath, 2002). Thus, we constructed embryos doubly
mutant for nmr1 or nmr2 in combination with dhb9kk30 or nkx6D26 to
determine whether nmr1 and nmr2 act with dhb9kk30 or nkx6D26 to
inhibit eve expression. nkx6D26 mutants exhibit a wild-type eve
expression pattern while dhb9kk30 single mutants exhibit 2–3 ectopic
Eve-positive neurons (Broihier and Skeath, 2002). Embryos doubly
mutant for nmr1 or nmr2 and dhb9kk30 do not enhance the Eve CNS
phenotype over each single mutant (data not shown). However,
embryos doubly mutant for nkx6D26 and nmr2 exhibit an increase of
ectopic Eve-positive neurons in the lateral CNS relative to either single
mutant (Figs. 10A–C). The increase in Eve-positive neurons peaks
around stage 12 and diminishes at later stages of development (Fig.
10D). These embryos also exhibit gross defects in the architecture of
the CNS, which preclude an ability to assess the exact number of Eve-
positive neurons beyond stage 14. We observe co-expression of Nkx6
with Nmr2 (Figs. 9E–G) and Nmr1 (Figs. 10H–J) in a single medial
neuron within each hemisegment at later stages of development
(stages 13–15). Thus, Nkx6 and Nmr2 are unlikely to act at the same
time in the same cells to repress eve in a cell autonomous manner.
Rather Nkx6 and Nmr2 may act together during earlier stages of
development, or sequentially in the same cells or cell lineage, to
inhibit eve expression; alternatively these factors may act in the same
cells or within the same lineage to initiate speciﬁc interneuronal
signaling events that inhibit eve expression in adjacent cells.
Discussion
The work presented here identiﬁes nmr1 and nmr2 as neuronal
fate determinants and conﬁrms that nmr1 and nmr2 act in a partially
redundant manner to repress eve expression in a small number ofneurons in the CNS (Buescher et al., 2006). In addition, it describes the
generation of Nmr1 and Nmr2 speciﬁc antibodies, which reveal
dynamic and cell-type speciﬁc expression proﬁles of these factors in
the CNS, heart and epidermis, while also providing evidence for post-
transcriptional regulation of nmr1. Through the use of these molecular
reagents, we reveal that most Nmr1/Nmr2-positive neurons deﬁne a
novel class of interneurons and map a subset of these cells to deﬁned
CNS lineages. Finally, we show that nmr1 and nmr2 exhibit cross-
repressive interactions with eve in the CNS, and that nmr2 acts with
nkx6D25 to repress the CNS expression of eve. Below we discuss our
results in light of the known genetic requirements for nmr1 and nmr2
function in the CNS and embryo, and highlight particular sequence
characteristics of these loci that suggest nmr1may be in the process of
undergoing non-functionalization.
Our detailed studies on the expression of Nmr1 protein and RNA
suggest that the nmr1 transcript is subject to post-transcriptional
regulation during early stages of embryogenesis. For example, while
the Nmr2 protein pattern faithfully recapitulates its RNA proﬁle, a
signiﬁcant temporal delay exists between the onset of nmr1
transcription and the initial detection of Nmr1 protein in a few cells
in the CNS (Fig. 2). Precedence exists for temporal regulation of mRNA
translation in the CNS. For example, the nerﬁn transcript, which codes
for a zinc-ﬁnger domain containing protein, is expressed in neuro-
blasts, GMCs and neurons but Nerﬁn protein is detected only in GMCs
and neurons due to the action of multiple microRNAs acting on the
nerﬁn 3′ UTR (Kuzin et al., 2005, 2007). In this context it is interesting
to note that the nmr1 transcript is predicted to contain a short 3′ UTR
and a long 538 bp 5′ UTR (Fig. S4). The 5′ UTR contains a number of
conserved sequence blocks towards its 5′ end. While these sequences
are not target sites for characterized microRNAs (Enright et al., 2003;
Stark et al., 2003), they may represent motifs through which RNA-
binding proteins or uncharacterized microRNAs mediate the transla-
tional silencing of nmr1. In the future it will be important to deﬁne the
relevant sequence motifs in the nmr1 transcript in order to begin to
deﬁne the cis- and trans-acting mechanisms responsible for its post-
transcriptional regulation.
We should note that it is formally possible that our Nmr1 speciﬁc
antibodies fail to recognize a protein isoform expressed during early
embryogenesis. However, we view this as unlikely due to the design of
the antibody and RNA probes. We generated Nmr1 speciﬁc antibodies
against a protein fragment that contained the ﬁrst two exons, and a
small region of the third exon, of nmr1 (see Methods), while an anti-
sense RNA probe generated from exons 1 and 2 detects the entirety of
the nmr1 transcript pattern. Thus, we believe the simplest interpreta-
tion of our data is that nmr1 is subject to post-transcriptional
regulation during early but not late embryogenesis.
Genetic studies reveal a key role for nmr2 during segmentation,
neuroblast formation and speciﬁcation, heart development and
neuronal speciﬁcation (Buescher et al., 2006; Reim et al., 2005;
Fig. 9. Nmr1 and Nmr2 repress eve expression. Wild-type stage 15 embryonic nerve cords stained for eve (A–C,H,I), Nmr2 (D,E,H,I), and Nmr1 (F,G). (A) Wild-type expression pattern
of eve within the ventral region of the CNS. (B) Misexpression of Nmr2 in all post-mitotic neurons (ElavGAL4::UAS-nmr2) signiﬁcantly reduces eve expression in all Eve-positive
neurons (arrow points to location of ELs). (C) Misexpression of Nmr1 throughout the CNS (ElavGAL4::UAS-nmr1) causes a mild decrease of eve expression (arrow points to ELs). (D,F)
Wild-type expression pattern of Nmr2 (D) and Nmr1 (F). (E,G) Expression of eve throughout the CNS (ElavGAL4::UAS-eve) results in a signiﬁcant decrease of Nmr2 (E) and Nmr1 (G).
(H,I) eve (red) exhibits a predominantly mutually exclusive expression patternwith Nmr2 (green) in the ventral (H) and dorsal (I) regions of the nerve cord while a single Eve-positive
U/CQ neuron (H) co-expresses Nmr2 (arrows).
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2004). In contrast, loss of nmr1 exhibits no phenotype on its own. In
fact, nmr1 has only been shown to contribute to nmr2 function due to
a modest enhancement of the severity of a subset of nmr2
phenotypes observed in embryos doubly-mutant for nmr1 and
nmr2 (Buescher et al., 2006; Qian et al., 2005). The clear differences
in the genetic requirements for nmr2 and nmr1 during embryonic
development have been difﬁcult to reconcile with the nearly identical
RNA expression proﬁles of these factors (Buescher et al., 2006; Qian
et al., 2005). In this context, our characterization of the proteinexpression proﬁles of Nmr1 and Nmr2 provide a molecular explana-
tion for the functional requirement of nmr1 during a subset of nmr2-
dependent events. For example, we observe co-expression of Nmr1
and Nmr2 protein in all cardioblasts and many CNS neurons,
consistent with nmr1 acting in a partly redundant manner to nmr2
in these tissues. In contrast, we do not observe Nmr1 protein in
neuroblasts, consistent with the lack of a genetic requirement for
nmr1 during neuroblast formation and speciﬁcation. Thus, nmr1
appears to contribute to nmr2 function, albeit weakly, in most or all
cells that co-express the two proteins.
Fig. 10. nmr2 and nkx6 collaborate to inhibit eve expression. (A–C) Stage 14 wild-type and mutant embryonic nerve cords stained for Eve, (D) a chart quantiﬁes the number of Eve-
positive lateral neurons in wild-type, nmr2−/−, and nmr2−/−;nkx6−/− mutant backgrounds at stages 12 and 14, (E–J) immunoﬂuorescent staining of Nmr2-, Nmr1-, and Nkx-6-positive
neurons in the CNS of stage 15 wild-type embryos. All images depict the ventral region of the CNS. (A) Stage 14 wild-type eve expression pattern. (B) As shown previously, nmr2−/−
mutant embryos exhibit Eve-positive ectopic lateral neurons (arrows, see Fig. 1B). (C) nmr2−/−;nkx6−/− double mutant embryos exhibit increased numbers of Eve-positive ectopic
lateral neurons throughout the nerve cord as compared with nmr2−/− mutants (arrows). The nerve cords of nmr2−/−;nkx6−/− mutants also exhibit severe orientation defects that
become pronounced at stages 15–16 (data not shown). (D) Each bar value represents the mean of 20 embryos scored for the number of Eve-positive ectopic lateral neurons observed
throughout the nerve cord at stages 12 and 14. The error bars represent the S.E.M. and statistical signiﬁcance was determined by One-way Analysis of Variance (ANOVA) where
p⁎⁎b0.001 and p⁎b0.01. (E–G) Nmr2 (green) and Nkx6 (red) exhibit a mutually exclusive expression pattern with the exception of one medial neuron per hemisegment that co-
expresses Nmr2 and Nkx6 (merge, arrows). (H–J) Nmr1 (green) and Nkx6 (red) are also co-expressed in one medial neuron per hemisegment.
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difﬁcult to explain, as we do not observe Nmr1 protein in segment
polarity stripes during early embryogenesis. Nmr1 and Nmr2
proteins are detected in narrow stripes of ventral ectodermal cells
during late embryogenesis (Fig. 2). Thus, nmr2 and nmr1 function in
these cells may help deﬁne the ﬁnal cuticular pattern of the Droso-
phila embryo (Buescher et al., 2006). Consistent with this model,
interactions between the Wingless, Notch and EGF signaling path-
ways in late stage embryos is critical to establish the ﬁnal cuticular
pattern of the Drosophila embryo (Walters et al., 2005; Alexandre et
al., 1999), and nmr2 has been shown to mediate its effect on
segmentation by negatively regulating wingless expression (Buescher
et al., 2004). Alternatively, the enhancement of the nmr2 segmenta-
tion phenotype observed in nmr1/nmr2 double mutant embryos
could arise due to heterozygosity for one or more genes, as
overlapping deﬁciencies were used to construct nmr1/nmr2 double-
mutant embryos.Our work, as well as prior studies, reveals that nmr1 and nmr2 act
together to control the speciﬁcation of eve-expressing neurons in the
CNS (Fig. 1; Buescher et al., 2006). However, due to the similar RNA
expression patterns of nmr1 and nmr2 in neuroblasts and neurons,
prior studies could not deﬁne whether nmr1 and nmr2 function in
post-mitotic neurons and/or neural precursors to control the devel-
opment of these cells. Our observation that Nmr1 protein is expressed
in post-mitotic neurons, but not in neural precursors, in the CNS
provides strong evidence that nmr1 and nmr2 act in post-mitotic
neurons to regulate eve expression. This late function for nmr1 and
nmr2 does not preclude nmr2 also acting earlier in the lineage to
help mediate this event, a possibility supported by the more severe
nature of the nmr2 phenotype with respect to Eve-positive neurons.
Nonetheless, our work reveals a functional role for nmr1 and nmr2 in
post-mitotic neurons, and thus places these factors in the combina-
torial code of transcription factors known to govern the speciﬁcation
and differentiation of post-mitotic neurons. Moreover, as nmr1 and
149S.M. Leal et al. / Developmental Biology 325 (2009) 138–150nmr2 are expressed in many neurons, they likely play a much broader
role during neuronal differentiation than simply regulating eve
expression.
nmr1 and nmr2 are paralogs and arose as the result of a duplication
of an ancestral Tbx-20 gene. Thus, nmr1 and nmr2 likely exhibited
essentially identical gene regulation in the ancestral species in which
they ﬁrst appeared. However, in Drosophila the regulation of nmr1 and
nmr2 display clear differences, with nmr2 exhibiting signiﬁcantly
higher RNA expression, and nmr1 being speciﬁcally subjected to post-
transcriptional regulation. Inspection of the nmr1 and nmr2 loci for
key regulatory sequences that promote gene transcription and
translation suggests greater selective pressure acts on nmr2 to retain
such motifs than on nmr1. For example, the nmr2 locus contains
conserved motifs that match the consensus sequences for the Initiator
and downstream promoter element (DPE), and for the Drosophila
Kozak sequence at its translation start site (Kutach and Kadonaga,
2000; Cavener, 1987). In contrast, we were unable to ﬁnd matches to
the consensus sequences for an Initiator, DPE or TATA box at the
predicted nmr1 promoter, while the nmr1 translation start site
contains an imperfect match to the Kozak sequence. We did identify
a consensus match to an Initiator motif 62 bp upstream of the
predicted start of transcription, after scanning 200 bp upstream and
downstream of the predicted promoter (Fig. S4). While this sequence
is conserved in drosophilids, it is not ﬂanked by a consensus TATA box
or DPE. Thus, heightened expression of nmr2 relative to nmr1 may
arise, at least in part, due to retention of key regulatory motifs critical
for appropriate gene transcription and translation. Together with the
paralogous nature of nmr1 and nmr2, these observations indicate that
nmr1 may be undergoing non-functionalization — a process often
thought to occur to one of two duplicate genes when neither gene
assumes a new function following duplication (Prince and Pickett,
2002).
Conclusion
nmr1 and nmr2 are members of the combinatorial code of
transcription factors that govern neuronal speciﬁcation and differ-
entiation. However, extensive expression studies between Nmr1/
Nmr2 and many transcription factors known to control motor neuron
and interneuron fates revealed little co-expression between these
factors (Fig. 5, data not shown). Thus, signiﬁcant additional work is
needed to decipher the functions of nmr1/nmr2 in neurons, and place
their action within the complex genetic regulatory hierarchy that
governs neuronal differentiation. In this context, our expression and
lineage studies, which identify a set of Nmr1/Nmr2-positive neurons
as GABAergic, and map a handful of Nmr1-expressing neurons to
deﬁned CNS cell lineages, represent a step towards establishing the
descriptive foundation required to dissect in detail the CNS functions
of nmr1 and nmr2. Clearly, it will be crucial to identify other
transcription factors expressed with Nmr1/Nmr2 in neurons, and to
deﬁne the target genes through which Nmr2/Nmr1 mediate their
effect on neuronal differentiation. Thus, we expect the integration of
traditional embryological methods with modern genome-wide
searches for transcription factor targets to begin to illuminate how
Nmr1/2, and other transcription factors, direct distinct sets of neurons
to differentiate from each other.
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